New findings on pre-exposure prophylaxis (PrEP) from both CDC and NIH were among the HIV research findings shared on July 21 at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) in Vancouver, Canada. Below are highlights of some of the information they have shared.
CDC Study Finds High Adherence to Daily PrEP among Both Men and WomenThe Centers for Disease Control and Prevention released new research showing high adherence to daily oral PrEP for HIV prevention among heterosexual men and women in Botswana. The data come from a 12-month open-label extension of the study known as TDF2. Key findings include:
- Both men and women were highly adherent to daily PrEP throughout the study period
- There were no HIV infections among study participants
- There was no increase in sexual risk behavior – in fact, sexual risk behavior among participants declined over the course of the study